Pharma’s Next Frontier: Middle East Manufacturing Boom as Saudi Arabia Hosts Inaugural CPHI Event

    Efforts to build a new manufacturing, biomanufacturing and R&D hub in Saudi Arabia and across the wider Middle East are accelerating as...

December 11, 2024 | Wednesday | News
Pfizer to Showcase Latest Hematology and Breast Cancer Advancements at ASH and SABCS 2024

Pfizer Inc. (NYSE: PFE) will highlight the latest advancements from its growing hematology and breast cancer portfolios at the American Society of Hematolo...

December 09, 2024 | Monday | News
Amgen Presents New Data on UPLIZNA and KRYSTEXXA at ACR Convergence 2024

Amgen (NASDAQ:AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheum...

November 15, 2024 | Friday | News
Exact Sciences to Present Key Findings on Multi-Cancer Early Detection Test at AACR Conference in San Diego

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant adv...

November 14, 2024 | Thursday | News
GenScript Biotech Global Forum 2024: Paving the Way for Innovation and Investment in Cell and Gene Therapy

- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments...

November 14, 2024 | Thursday | News
Fate Therapeutics Unveils Promising Preclinical Data for FT836, a Next-Generation iPSC-Derived CAR T-Cell Therapy Targeting MICA/B at SITC 2024

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripot...

November 12, 2024 | Tuesday | News
Gilead Sciences to Present Groundbreaking HIV Research at HIV Glasgow 2024, Highlighting Advances in Treatment and Prevention

Gilead Sciences, Inc. (Nasdaq: GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infe...

November 08, 2024 | Friday | News
Poseida Therapeutics to Present New Preclinical Data and Clinical Insights at SITC and ASH 2024

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral t...

November 06, 2024 | Wednesday | News
bluebird bio to Present New Data on Gene Therapies for Sickle Cell Disease and Beta-Thalassemia at ASH 2024

bluebird bio, Inc. (Nasdaq: BLUE) announced that new and updated data from its lentiviral vector (LVV) gene addition programs in patients with sickle cell ...

November 06, 2024 | Wednesday | News
Complete Genomics Showcases Expanded Applications and Innovations for DNBSEQ-T7 at ASHG 2024

At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highligh...

November 05, 2024 | Tuesday | News
BioCity Biopharma Unveils Positive Late-Breaking Results from 2-SUCCEED Trial of SC0062 for IgA Nephropathy at ASN Kidney Week 2024

BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062, a selective endothelin receptor type A (ETA) an...

November 05, 2024 | Tuesday | News
Eisai and Biogen Showcase Promising Long-Term Data for Lecanemab in Early Alzheimer’s Disease at CTAD 2023

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 01, 2024 | Friday | News
Bristol Myers Squibb to Present New Data on COBENFY™ for Schizophrenia at Psych Congress 2024

Bristol Myers Squibb (NYSE: BMY) announced that new clinical and health economics and outcomes research data (HEOR) from its neuropsychiatry portfolio...

October 29, 2024 | Tuesday | News
Novartis Unveils Promising 12-Month Data for Fabhalta® in C3 Glomerulopathy at ASN Kidney Week 2024

Novartis presented 12-month data from the Phase III APPEAR-C3G study at American Society of Nephrology (ASN) Kidney Week 2024 showing that patients with C3...

October 28, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close